Gedeon Richter files biosimilar RoActemra with European agency
- ByInvesting.com-
Investing.com -- Gedeon Richter has submitted a biosimilar version of Roche’s RoActemra (tocilizumab) to the European Medicines...
Last | High | Low | |||||
---|---|---|---|---|---|---|---|
25,350.0 | 25,570.0 | 25,100.0 | -380.0 | -1.48% | 93.33K | ||
2,888.0 | 2,900.0 | 2,870.0 | -14.0 | -0.48% | 42.88K | ||
10,050.0 | 10,090.0 | 10,040.0 | -80.0 | -0.79% | 5.96K | ||
1,764.0 | 1,768.0 | 1,756.0 | -4.0 | -0.23% | 85.06K | ||
1,440.0 | 1,455.0 | 1,440.0 | -20.0 | -1.37% | 2K | ||
8,600.0 | 8,600.0 | 8,400.0 | +120.0 | +1.42% | 9.53K | ||
53.200 | 53.600 | 53.200 | -1.200 | -2.21% | 9.67K | ||
369.0 | 369.0 | 369.0 | +1.0 | +0.27% | 231 | ||
670.0 | 693.0 | 670.0 | -28.0 | -4.01% | 34.8K | ||
12.7 | 12.7 | 12.7 | +0.1 | +0.79% | 105 | ||
550.00 | 554.00 | 542.00 | 0.00 | 0.00% | 29.88K | ||
1,750.0 | 1,776.0 | 1,750.0 | -10.0 | -0.57% | 27.9K | ||
2,330.0 | 2,350.0 | 2,330.0 | 0.0 | 0.00% | 11 | ||
5,280.0 | 5,280.0 | 5,280.0 | 0.0 | 0.00% | 143 | ||
4,870.00 | 4,900.00 | 4,870.00 | -60.00 | -1.22% | 405 | ||
157.50 | 158.00 | 157.50 | -2.50 | -1.56% | 9.74K |
Investing.com -- Gedeon Richter has submitted a biosimilar version of Roche’s RoActemra (tocilizumab) to the European Medicines...
Investing.com -- Shares of MOL Group (BUD:MOL) fell by 1% following the release of its fourth-quarter results, which showed Clean...
Investing.com -- Despite European equities reaching all-time highs, 66% of fund managers expect further near-term gains, according...
No Earning Reports have been scheduled